Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Differential modulation of cell cycle, apoptosis and PPARgamma2 gene expression by PPARgamma agonists ciglitazone and 9-hydroxyoctadecadienoic acid in monocytic cells.

Hampel JK, Brownrigg LM, Vignarajah D, Croft KD, Dharmarajan AM, Bentel JM, Puddey IB, Yeap BB.

Prostaglandins Leukot Essent Fatty Acids. 2006 May;74(5):283-93. Epub 2006 May 2.

PMID:
16647253
2.

Hydroxyoctadecadienoic acids regulate apoptosis in human THP-1 cells in a PPARγ-dependent manner.

Vangaveti VN, Shashidhar VM, Rush C, Malabu UH, Rasalam RR, Collier F, Baune BT, Kennedy RL.

Lipids. 2014 Dec;49(12):1181-92. doi: 10.1007/s11745-014-3954-z. Epub 2014 Oct 21.

PMID:
25330944
3.

The synthetic ligand of peroxisome proliferator-activated receptor-gamma ciglitazone affects human glioblastoma cell lines.

Strakova N, Ehrmann J, Dzubak P, Bouchal J, Kolar Z.

J Pharmacol Exp Ther. 2004 Jun;309(3):1239-47. Epub 2004 Feb 26.

4.

Differential cell growth/apoptosis behavior of 13-hydroxyoctadecadienoic acid enantiomers in a colorectal cancer cell line.

Cabral M, Martín-Venegas R, Moreno JJ.

Am J Physiol Gastrointest Liver Physiol. 2014 Sep 15;307(6):G664-71. doi: 10.1152/ajpgi.00064.2014. Epub 2014 Jul 17.

5.

Modulation of cell growth and PPARgamma expression in human colorectal cancer cell lines by ciglitazone.

Yaacob NS, Darus HM, Norazmi MN.

Exp Toxicol Pathol. 2008 Sep;60(6):505-12. doi: 10.1016/j.etp.2008.05.006. Epub 2008 Jun 24.

PMID:
18579355
6.

Effects of 15-deoxy-Delta12, 14 prostaglandin J2 and ciglitazone on human cancer cell cycle progression and death: the role of PPARgamma.

Ferreira-Silva V, Rodrigues AC, Hirata TD, Hirabara SM, Curi R.

Eur J Pharmacol. 2008 Feb 2;580(1-2):80-6. Epub 2007 Nov 17.

PMID:
18054911
7.

Activation of peroxisome proliferator-activated receptor-gamma (PPARgamma) induces cell death through MAPK-dependent mechanism in osteoblastic cells.

Kim SH, Yoo CI, Kim HT, Park JY, Kwon CH, Kim YK.

Toxicol Appl Pharmacol. 2006 Sep 1;215(2):198-207. Epub 2006 Apr 17.

PMID:
16616945
8.

Peroxisome proliferator-activated receptor-gamma agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines.

Yang YC, Tsao YP, Ho TC, Choung IP.

Int J Gynecol Cancer. 2007 Mar-Apr;17(2):418-25. Epub 2007 Feb 19.

PMID:
17316361
9.

Ciglitazone induces caspase-independent apoptosis through down-regulation of XIAP and survivin in human glioma cells.

Kang DW, Choi CH, Park JY, Kang SK, Kim YK.

Neurochem Res. 2008 Mar;33(3):551-61. Epub 2007 Oct 17.

PMID:
17940898
10.
11.

Pioglitazone prevents smoking carcinogen-induced lung tumor development in mice.

Li MY, Kong AW, Yuan H, Ma LT, Hsin MK, Wan IY, Underwood MJ, Chen GG.

Curr Cancer Drug Targets. 2012 Jul;12(6):597-606.

PMID:
22463586
12.

Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells.

Cheon CW, Kim DH, Kim DH, Cho YH, Kim JH.

World J Gastroenterol. 2009 Jan 21;15(3):310-20.

13.

Effects of PPARgamma agonists on cell survival and focal adhesions in a Chinese thyroid carcinoma cell line.

Chen Y, Wang SM, Wu JC, Huang SH.

J Cell Biochem. 2006 Jul 1;98(4):1021-35.

PMID:
16795079
14.
15.
16.

The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells.

Moss PE, Lyles BE, Stewart LV.

Exp Cell Res. 2010 Dec 10;316(20):3478-88. doi: 10.1016/j.yexcr.2010.09.015. Epub 2010 Oct 13.

17.

Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression.

Hounoki H, Sugiyama E, Mohamed SG, Shinoda K, Taki H, Abdel-Aziz HO, Maruyama M, Kobayashi M, Miyahara T.

Bone. 2008 Apr;42(4):765-74. doi: 10.1016/j.bone.2007.11.016. Epub 2007 Dec 15.

PMID:
18242157
18.

The antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAIL.

Plissonnier ML, Fauconnet S, Bittard H, Lascombe I.

PLoS One. 2011;6(12):e28354. doi: 10.1371/journal.pone.0028354. Epub 2011 Dec 12.

19.

Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells.

Meshkani R, Sadeghi A, Taheripak G, Zarghooni M, Gerayesh-Nejad S, Bakhtiyari S.

Cell Biochem Funct. 2014 Dec;32(8):683-91. doi: 10.1002/cbf.3072. Epub 2014 Nov 28.

PMID:
25431031
20.

In vitro and in vivo anti-melanoma effects of ciglitazone.

Botton T, Puissant A, Bahadoran P, Annicotte JS, Fajas L, Ortonne JP, Gozzerino G, Zamoum T, Tartare-Deckert S, Bertolotto C, Ballotti R, Rocchi S.

J Invest Dermatol. 2009 May;129(5):1208-18. doi: 10.1038/jid.2008.346. Epub 2009 Jan 29.

Supplemental Content

Support Center